Making Blood Types Obsolete with Peter Rahfeld, CSO at ABOzymes
Joel Beasley | Modern CTO
English - May 11, 2022 13:00 - 33 minutes - ★★★★★ - 54 ratingsTechnology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Molecular Beverage Printing with Matt Mahar, CEO of Cana
Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com
Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com